Circulating free DNA as a diagnostic marker for echinococcosis: a systematic review and meta-analysis

被引:0
|
作者
Luo, Xiaoqin [1 ,2 ]
Jiang, Ping [1 ]
Ma, Jideng [1 ]
Li, Zian [2 ]
Zhou, Jianwu [2 ]
Wei, Xiaoxing [1 ]
A, Jide [2 ]
Chai, Jinping [2 ]
Lv, Yanke [1 ]
Cheng, Peng [1 ]
Cao, Chunhua [1 ]
A, Xiangren [1 ,2 ]
机构
[1] Qinghai Univ, Xining, Peoples R China
[2] Qinghai Prov Peoples Hosp, Dept Clin Lab, Xining, Peoples R China
基金
中国国家自然科学基金;
关键词
echinococcosis; circulating free DNA; diagnostic marker; systematic review; meta-analysis; CELL-FREE DNA; ALVEOLAR ECHINOCOCCOSIS; FETAL DNA; PLASMA; FLUID; TOOL; DISEASE; TESTS;
D O I
10.3389/fmicb.2024.1413532
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Introduction: Echinococcosis is a chronic zoonotic disease caused by tapeworms of the genus Echinococcus. The World Health Organization (WHO) has identified encapsulated disease as one of 17 neglected diseases to be controlled or eliminated by 2050. There is no accurate, early, non-invasive molecular diagnostic method to detect echinococcosis. The feasibility of circulating free DNA as a diagnostic method for echinococcosis has yielded inconclusive results in a number of published studies. However, there has been no systematic evaluation to date assessing the overall performance of these assays. We report here the first meta-analysis assessing the diagnostic accuracy of cfDNA in plasma, serum, and urine for echinococcosis. Methods: We systematically searched PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), and WeiPu databases up to 17 January 2024, for relevant studies. All analyses were performed using RevMan 5.3, Meta-DiSc 1.4, Stata 17.0, and R 4.3.1 software. The sensitivity, specificity, and other accuracy indicators of circulating free DNA for the diagnosis of echinococcosis were summarized. Subgroup analyses and meta-regression were performed to identify sources of heterogeneity. Results: A total of 7 studies included 218 patients with echinococcosis and 214 controls (156 healthy controls, 32 other disease controls (non-hydatid patients), and 26 non-study-targeted echinococcosis controls were included). Summary estimates of the diagnostic accuracy of cfDNA in the diagnosis of echinococcosis were as follows: sensitivity (SEN) of 0.51 (95% CI: 0.45-0.56); specificity (SPE) of 0.99 (95% CI: 0.97-0.99); positive likelihood ratio (PLR) of 11.82 (95% CI: 6.74-20.74); negative likelihood ratio (NLR) of 0.57 (95% CI: 0.41-0.80); diagnostic ratio (DOR) of 36.63 (95% CI: 13.75-97.59); and area under the curve (AUC) value of 0.98 (95% CI: 0.96-1.00). Conclusion: Existing evidence indicates that the combined specificity of circulating cfDNA for echinococcosis is high. However, the combined sensitivity performance is unsatisfactory due to significant inter-study heterogeneity. To strengthen the validity and accuracy of our findings, further large-scale prospective studies are required.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Cell-free DNA as a Promising Diagnostic Biomarker in Prostate Cancer: A Systematic Review and Meta-Analysis
    Zhang, Cong
    Chao, Fan
    Wang, Shiyu
    Han, Dunsheng
    Chen, Gang
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [42] Diagnostic accuracy of Mycobacterium tuberculosis cell-free DNA for tuberculosis: A systematic review and meta-analysis
    Yu, Guocan
    Shen, Yanqin
    Ye, Bo
    Shi, Yan
    PLOS ONE, 2021, 16 (06):
  • [43] The assessment of circulating cell-free DNA as a diagnostic tool for breast cancer: an updated systematic review and meta-analysis of quantitative and qualitative ssays
    Guo, Qingfeng
    Hua, Yuming
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2021, 59 (09) : 1479 - 1500
  • [44] Diagnostic accuracy of circulating-free DNA for the determination of MYCN amplification status in advanced-stage neuroblastoma: a systematic review and meta-analysis
    Ricky M. Trigg
    Suzanne D. Turner
    Jacqueline A. Shaw
    Leila Jahangiri
    British Journal of Cancer, 2020, 122 : 1077 - 1084
  • [45] Circulating cell-free DNA as a diagnostic and prognostic biomarker for non-small-cell lung cancer: a systematic review and meta-analysis
    Chen, Zhoumiao
    Miao, Huiwen
    Zeng, Qingxin
    Xu, Shaohua
    Chen, Zhao
    Liu, Kai
    BIOMARKERS IN MEDICINE, 2020, 14 (07) : 587 - 598
  • [46] Diagnostic accuracy of circulating-free DNA for the determination of MYCN amplification status in advanced-stage neuroblastoma: a systematic review and meta-analysis
    Trigg, Ricky M.
    Turner, Suzanne D.
    Shaw, Jacqueline A.
    Jahangiri, Leila
    BRITISH JOURNAL OF CANCER, 2020, 122 (07) : 1077 - 1084
  • [47] Circulating tumour DNA (ctDNA) in metastatic melanoma, a systematic review and meta-analysis
    Gracie, Lara
    Pan, Yi
    Atenafu, Eshetu G.
    Ward, Douglas G.
    Teng, Mabel
    Pallan, Lallit
    Stevens, Neil M.
    Khoja, Leila
    EUROPEAN JOURNAL OF CANCER, 2021, 158 : 191 - 207
  • [48] Circulating tumour DNA and melanoma survival: A systematic literature review and meta-analysis
    Gandini, Sara
    Zanna, Ines
    Angelis, Simone Pietro De
    Cocorocchio, Emilia
    Queirolo, Paola
    Lee, Jenny H.
    Carlino, Matteo S.
    Mazzarella, Luca
    Duso, Bruno Achutti
    Palli, Domenico
    Raimondi, Sara
    Caini, Saverio
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 157
  • [49] Quantitative Analysis of Circulating Cell-Free DNA for Correlation with Lung Cancer Survival: A Systematic Review and Meta-Analysis
    Cargnin, Sarah
    Canonico, Pier Luigi
    Genazzani, Armando A.
    Terrazzino, Salvatore
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : 43 - 53
  • [50] Association of Circulating Tumor DNA With Disease-Free Survival in Breast Cancer A Systematic Review and Meta-analysis
    Cullinane, Carolyn
    Fleming, Christina
    O'Leary, Donal Peter
    Hassan, Fara
    Kelly, Louise
    O'Sullivan, Martin J.
    Corrigan, Mark Antony
    Redmond, Henry Paul
    JAMA NETWORK OPEN, 2020, 3 (11)